{"ticker": {"uuid": "f9a7520a-53c1-4ef9-b2aa-b54424be1e31", "symbol": "SEPN", "name": "Septerna, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Septerna president & COO Elizabeth Bhatt sells $135,974 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPWFlPVXlxUnE2VWVoMWFXYjNMMURPWjYxcEJrM3V4V1FWc0lhY0cyeEpMck13VnpZWVZqTGJVVWZBMUtjRF9qY0RFTDZneVZiYzhXQ2U1Y1ItSzZTUjNiX204QlhBN1liajB4bnlBXzBISEhHUUZ6VG8tai16eUwyQnhEeGN0VUdaa2pFN2ZoOTdsVmo1cEc0ZUp5d0pkcVh6SERsX2ZlSnV1bjlXWm1taEJ3UnBYYkpRazAyc3czLW1qTkYt?oc=5", "source_name": "Investing.com", "published_at": "2026-07-17T23:17:33+00:00", "published_display": "17 Jul 2026 23:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Septerna Inc For: 17 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Septerna Inc. on July 17. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders whenever they buy or sell shares of their company's stock. The article i", "url": "https://ng.investing.com/news/stock-market-news/form-4-septerna-inc-for-17-july-93CH-2605900", "source_name": "Investing.com Nigeria", "published_at": "2026-07-17T23:11:19", "published_display": "17 Jul 2026 23:11", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "[144] Septerna, Inc. SEC Filing", "summary": "This article reports on a Form 144 SEC filing by Septerna, Inc. (SEPN) on July 15, 2026. The filing indicates a proposed sale of 4000 shares of common stock with an aggregate market value of $138,160.00, acquired through the exercise of stock options. The neutrality of the filing", "url": "https://www.stocktitan.net/sec-filings/SEPN/144-septerna-inc-sec-filing-f6fa023ee862.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:46:45", "published_display": "15 Jul 2026 20:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) Is Up 7.1% After Broad Russell Growth Index Additions Has The Bull Case Changed?", "summary": "Septerna (SEPN) experienced a 7.1% stock increase following its inclusion in several Russell growth and small-cap indices in June 2026. While this broad index inclusion boosts visibility and eligibility for index-tracking funds, it doesn't fundamentally alter the immediate invest", "url": "https://www.sahmcapital.com/news/content/septerna-sepn-is-up-71-after-broad-russell-growth-index-additions-has-the-bull-case-changed-2026-07-09", "source_name": "Sahm", "published_at": "2026-07-10T16:09:17", "published_display": "10 Jul 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna Inc stock hits all-time high at 38.01 USD", "summary": "Septerna Inc (SEPN) stock has reached an all-time high of $38.01, marking a significant milestone for the biotech firm with a market capitalization of $1.71 billion. The company has seen a 224.66% increase in its stock price over the past year, reflecting strong investor confiden", "url": "https://www.investing.com/news/company-news/septerna-inc-stock-hits-alltime-high-at-3801-usd-93CH-4784717", "source_name": "Investing.com", "published_at": "2026-07-10T09:10:45", "published_display": "10 Jul 2026 09:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna Inc stock hits all-time high at 38.01 USD By Investing.com", "summary": "Septerna Inc's stock has reached an all-time high of $38.01, bringing its market capitalization to $1.71 billion. The company has seen a 224.66% increase in its stock price over the past year, reflecting strong investor confidence and strategic advancements. Analysts have varied ", "url": "https://in.investing.com/news/stock-market-news/septerna-inc-stock-hits-alltime-high-at-3801-usd-93CH-5490140", "source_name": "Investing.com India", "published_at": "2026-07-09T21:09:17", "published_display": "09 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$SEPN stock is up 10% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOaFRISk56a2lIZUtJVFZNS2puWjhhcFV4dU5pM2dvaGE2WEcxY0dFcHozdGQyOU5SQm5iVGU5cFRHRXVSeUVCRVlXREtfYVZwbUowRWZwN1BZMTdnbjNOZFJ1VVRMa0dWTkk3a05aaXZLbWxlQkEtRGctTm4xcXAwYTBiUEFreEUzUUJkYXROU3VnY1V1cDM2emk4MVFZS3VX?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-07T14:51:00+00:00", "published_display": "07 Jul 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Septerna, Inc. (SEPN)", "summary": "This article analyzes the hypothetical return on a $1,000 investment in Septerna, Inc. (SEPN), a clinical-stage biotechnology company specializing in GPCR-targeted therapies. An investment made one year ago would have yielded a 213.4% return, turning $1,000 into $3,134. The compa", "url": "https://www.stocktitan.net/tools/stock-return-calculator/SEPN", "source_name": "Stock Titan", "published_at": "2026-07-04T07:11:05", "published_display": "04 Jul 2026 07:11", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) SVP Long exercises options and sells 3,333 shares in Rule 10b5-1 trades", "summary": "Daniel D. Long, Senior Vice President of Drug Discovery at Septerna, Inc. (SEPN), exercised stock options to acquire 3,333 shares at $2.76 each and simultaneously sold these 3,333 shares in open-market transactions on July 1, 2026. The sales were conducted under a pre-arranged Ru", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-5138f5c509e8.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:39:28", "published_display": "02 Jul 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Strategy (MSTR)", "summary": "Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Septerna, Inc. (SEPN) with a $45.00 price target, reflecting a current consensus Strong Buy with a 38.9% upside. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating on Strategy (MSTR) with a $130.00 price ta", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3095991/analysts-offer-insights-on-technology-companies-septerna-inc-sepn-and-strategy-mstr/", "source_name": "The Globe and Mail", "published_at": "2026-07-02T11:14:42", "published_display": "02 Jul 2026 11:14", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPSmo4YkZqRzB2WkVGaVVqYmoxTXJRX3d0eXB2eU9heGM5cmVlNElpNG9zX0RaeUdOZzRQVEJ2MGFSUTZncmp4clZaaFdrZUc1M2NlcnN1Nmp5ODk1eFl6eXBQNWtxcENYbi03b2dSVGtzaWd4Um5ZaGVtRjhCalNQU2NaRDQwaFdtbGNiU1FjMlg5THVmX0tR?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Securities Adjusts Septerna Price Target to $43 From $35, Maintains Buy Rating", "summary": "Truist Securities has increased its price target for Septerna, Inc. (NasdaqGM:SEPN) to $43 from $35, while reiterating a \"Buy\" rating on the stock. This adjustment reflects an updated positive outlook from the firm regarding the biotechnology company. Septerna is a clinical-stage", "url": "https://www.marketscreener.com/news/truist-securities-adjusts-septerna-price-target-to-43-from-35-maintains-buy-rating-ce7f5fd2d98ff026", "source_name": "www.marketscreener.com", "published_at": "2026-07-01T12:42:24", "published_display": "01 Jul 2026 12:42", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) Is Down 7.1% After Broad Russell Index Additions Has The Bull Case Changed?", "summary": "Septerna, Inc. (NasdaqGM: SEPN) was recently added to several Russell growth and small-cap indexes in late June 2026, which could increase its visibility among institutional investors. Despite a recent 7-day share price decline, this index inclusion primarily impacts trading liqu", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-is-down-71-after-broad-russell-index-additions", "source_name": "Simply Wall Street", "published_at": "2026-07-01T12:42:24", "published_display": "01 Jul 2026 12:42", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna stock maintained at Buy by H.C. Wainwright after rival setback", "summary": "H.C. Wainwright has reiterated a Buy rating and a $40 price target for Septerna Inc (NASDAQ:SEPN) despite a competitor's negative Phase 2b data in chronic spontaneous urticaria. The firm maintains that Septerna's drug SEP-631, which targets the same condition, still has potential", "url": "https://ca.investing.com/news/stock-market-news/septerna-stock-maintained-at-buy-by-hc-wainwright-after-rival-setback-93CH-4715918", "source_name": "Investing.com Canada", "published_at": "2026-07-01T11:42:24", "published_display": "01 Jul 2026 11:42", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim cuts Septerna stock price target to $45 on CSU study risk", "summary": "Guggenheim lowered its price target for Septerna Inc. (NASDAQ:SEPN) to $45 from $52, while maintaining a Buy rating. This adjustment follows a competitor's failed Phase 2b study for chronic spontaneous urticaria (CSU), increasing the perceived risk for Septerna's similar drug can", "url": "https://www.investing.com/news/analyst-ratings/guggenheim-cuts-septerna-stock-price-target-to-45-on-csu-study-risk-93CH-4770149", "source_name": "Investing.com", "published_at": "2026-07-01T07:26:06", "published_display": "01 Jul 2026 07:26", "sentiment": "negative", "sentiment_pct": 40, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director Abraham Bassan receives grant of 15,000 stock options", "summary": "Septerna, Inc. director Abraham Bassan was granted 15,000 stock options with an exercise price of $37.34 per share, expiring on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the date of Septerna's next annual meeting of stockholders, provided ", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-c38ef471a367.html", "source_name": "Stock Titan", "published_at": "2026-07-01T06:09:26", "published_display": "01 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna chief people officer Samira Shaikhly sells $76,622 in stock", "summary": "Samira Shaikhly, Septerna's Chief People Officer, sold 2,178 shares of the company's common stock for $76,622 after exercising stock options. The sale was conducted under a Rule 10b5-1 trading plan. This transaction follows a significant 216% surge in Septerna's share price over ", "url": "https://m.uk.investing.com/news/stock-market-news/septerna-chief-people-officer-samira-shaikhly-sells-76622-in-stock-93CH-4751763?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-01T05:39:52", "published_display": "01 Jul 2026 05:39", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director Jeffrey Tong granted options on 15,000 shares", "summary": "Septerna, Inc. director Jeffrey K. Tong was granted stock options for 15,000 shares of common stock. The options have an exercise price of $37.34 per share and expire on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the date of Septerna\u2019s next", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-fef761c8d72a.html", "source_name": "Stock Titan", "published_at": "2026-07-01T05:39:52", "published_display": "01 Jul 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director Bernard Coulie receives 15,000 stock options", "summary": "Septerna, Inc. (SEPN) director Bernard Coulie was granted 15,000 stock options with an exercise price of $37.34 per share, expiring on June 25, 2036. The options will vest in full by the earlier of June 26, 2027, or the company's next annual stockholders' meeting, provided he con", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-e355f5e8dfdf.html", "source_name": "Stock Titan", "published_at": "2026-07-01T00:42:24", "published_display": "01 Jul 2026 00:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (NASDAQ: SEPN) director-linked funds get 15,000-share option", "summary": "Septerna, Inc. (NASDAQ: SEPN) has granted a stock option for 15,000 shares of common stock at an exercise price of $37.34, expiring on June 25, 2036. This option, which vests upon the earlier of June 26, 2027, or the next annual stockholder meeting, is held by Dr. Simson for the ", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-4aef99e2cf47.html", "source_name": "Stock Titan", "published_at": "2026-07-01T00:39:52", "published_display": "01 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director Shalini Sharp receives stock options on 15,000 shares", "summary": "Septerna, Inc. director Shalini Sharp was granted stock options for 15,000 shares of common stock. The options have an exercise price of $37.34 per share and will expire on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the company's next annua", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-136ae8e4ccbb.html", "source_name": "Stock Titan", "published_at": "2026-06-30T22:42:24", "published_display": "30 Jun 2026 22:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $60", "summary": "Cantor Fitzgerald has reiterated its Buy rating for Septerna (SEPN.US) and increased the price target to $60. This adjustment reflects the firm's continued positive outlook on the company's stock performance.", "url": "https://www.moomoo.com/news/post/72262745/cantor-fitzgerald-maintains-septerna-sepnus-with-buy-rating-raises-target", "source_name": "Moomoo", "published_at": "2026-06-30T16:39:52", "published_display": "30 Jun 2026 16:39", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director receives stock option grant for 11,260 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUG5vOHJILWlLR19tcmlONkUwakNUbHRCT0FhZ3FGTm1NNkF6a0NZY3dVYTJyNENiMXFwX0hTWVRyS0VGazRFM3pEVzc1OW83NlkwXzF6ZHpyMGgzSjBmTXBvem9xTEoyYndnNTNwbnlIWjNFNFNVUTBhTmZuOXU2Q3MwUjJOVGRfTUlZUE00LXliV1cwSE0zREZ1Y3F3Zlc5Q2VBSjFhblBrQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (NASDAQ: SEPN) 2026 meeting elects directors and backs EY as auditor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPdUhfdWR5VTcyWGt6R080S3FKUUJYRlg3MEdkYVNMWGpqS0FFejZrcXVyV1FoQzNINXdITzc3R1BFU095Njd0aWY0VUtzV2pWR0dnZWlBZjlpRUpQelZHNmYza3ozblhndGpJLTY2QmZzN09sdlJ5MC00Wm5DcVRKNXo3UEtKNmJBMjNBVEpsRkRlWjJONXBqeWJ3VEJQX2dab2xN?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?", "summary": "An insider at Septerna, Daniel D. Long, SVP of Drug Discovery, sold 15,000 shares of common stock after exercising options, reducing his direct holdings by 13.46%. Despite this sale, the article suggests it's likely a form of income supplementation rather than a lack of confidenc", "url": "https://finance.yahoo.com/markets/stocks/articles/septerna-stock-sell-insider-let-032501051.html", "source_name": "Market source", "published_at": "2026-06-30T03:10:47", "published_display": "30 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Septerna, Inc. Stocks", "summary": "This article lists various ETFs that hold Septerna, Inc. (SEPN) stocks, providing detailed information such as market value, weight, issuer, management style, focus, and expense ratio for each fund. The data highlights ETFs from major issuers like BlackRock, State Street, and Inv", "url": "https://www.tradingview.com/symbols/NASDAQ-SEPN/etfs/", "source_name": "TradingView", "published_at": "2026-06-29T16:10:47", "published_display": "29 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna, Inc.(NasdaqGM:SEPN) added to Russell 2000 Growth Benchmark", "summary": "Septerna, Inc. (NasdaqGM: SEPN) has been included in the Russell 2000 Growth Benchmark, a significant development for the clinical-stage biotechnology company. This inclusion indicates increased visibility and potential liquidity for Septerna's stock. The company focuses on devel", "url": "https://www.marketscreener.com/news/septerna-inc-nasdaqgm-sepn-added-to-russell-2000-growth-benchmark-ce7f5fded18dfe21", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T11:11:27", "published_display": "29 Jun 2026 11:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SEPN (NASDAQ) insider sale: JAE KIM sells 94,339 shares under Rule 144", "summary": "JAE KIM, an insider at Septerna, Inc. (NASDAQ: SEPN), sold 94,339 shares of common stock on June 22, 2026, for proceeds of $3,326,119.56, as reported in a Rule 144 filing on June 26, 2026. This notice details proposed transactions of restricted shares and also lists prior Employe", "url": "https://www.stocktitan.net/sec-filings/SEPN/144-septerna-inc-sec-filing-47f6ebded44f.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:40:02", "published_display": "26 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Party Time: Brokers Just Made Major Increases To Their Septerna, Inc. (NASDAQ:SEPN) Earnings Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQNUZyR3E3WkNKX0l5MWpraTBOWWtDeEl6ZXRmZzF1LXVFVFVQVnJ1VXJDaFYyRnAtamlwNG5HbXQ3a0FBTExKby0wUHBMd1FVRVhjOV94aWJYY3pRc1p3QjR0bWpBZHdmT0dPTUNtLW5DN2JuaG4wRVNrZ2NfVFl5cS11TWwzMHlveHNrUzRxMmQ5MWhSdHk3bQ?oc=5", "source_name": "Market source", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Septerna, Inc. (NASDAQ:SEPN) Just Reported And Analysts Are Boosting Their Estimates", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/earnings-septerna-inc-nasdaq-sepn-140848094.html", "source_name": "Simply Wall St.", "published_at": "2026-05-15T14:08:48+00:00", "published_display": "15 May 2026 14:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPRHVXU0Z5SEpiVXp2TGNMS0drQ2J1M0R6N0wxS1oxcGh1R1ZrYWFySVNuQ0ZQNzlDS09tVkJ2SVJnYjdmdFBXZ3VrdUR2OXViWUZPSVV2UHByYnVyanFDcGpwSkhiV1FDYkhLYVNaMDl3UDE2VFFPd01FTGx1YVZ6dkkxX21uNVhzNm5nd05YRE8yTWQ2bk5RRA?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Septerna president & COO Elizabeth Bhatt sells $135,974 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPWFlPVXlxUnE2VWVoMWFXYjNMMURPWjYxcEJrM3V4V1FWc0lhY0cyeEpMck13VnpZWVZqTGJVVWZBMUtjRF9qY0RFTDZneVZiYzhXQ2U1Y1ItSzZTUjNiX204QlhBN1liajB4bnlBXzBISEhHUUZ6VG8tai16eUwyQnhEeGN0VUdaa2pFN2ZoOTdsVmo1cEc0ZUp5d0pkcVh6SERsX2ZlSnV1bjlXWm1taEJ3UnBYYkpRazAyc3czLW1qTkYt?oc=5", "source_name": "Investing.com", "published_at": "2026-07-17T23:17:33+00:00", "published_display": "17 Jul 2026 23:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Septerna Inc For: 17 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Septerna Inc. on July 17. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders whenever they buy or sell shares of their company's stock. The article i", "url": "https://ng.investing.com/news/stock-market-news/form-4-septerna-inc-for-17-july-93CH-2605900", "source_name": "Investing.com Nigeria", "published_at": "2026-07-17T23:11:19", "published_display": "17 Jul 2026 23:11", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Septerna, Inc. SEC Filing", "summary": "This article reports on a Form 144 SEC filing by Septerna, Inc. (SEPN) on July 15, 2026. The filing indicates a proposed sale of 4000 shares of common stock with an aggregate market value of $138,160.00, acquired through the exercise of stock options. The neutrality of the filing", "url": "https://www.stocktitan.net/sec-filings/SEPN/144-septerna-inc-sec-filing-f6fa023ee862.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:46:45", "published_display": "15 Jul 2026 20:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) Is Up 7.1% After Broad Russell Growth Index Additions Has The Bull Case Changed?", "summary": "Septerna (SEPN) experienced a 7.1% stock increase following its inclusion in several Russell growth and small-cap indices in June 2026. While this broad index inclusion boosts visibility and eligibility for index-tracking funds, it doesn't fundamentally alter the immediate invest", "url": "https://www.sahmcapital.com/news/content/septerna-sepn-is-up-71-after-broad-russell-growth-index-additions-has-the-bull-case-changed-2026-07-09", "source_name": "Sahm", "published_at": "2026-07-10T16:09:17", "published_display": "10 Jul 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna Inc stock hits all-time high at 38.01 USD", "summary": "Septerna Inc (SEPN) stock has reached an all-time high of $38.01, marking a significant milestone for the biotech firm with a market capitalization of $1.71 billion. The company has seen a 224.66% increase in its stock price over the past year, reflecting strong investor confiden", "url": "https://www.investing.com/news/company-news/septerna-inc-stock-hits-alltime-high-at-3801-usd-93CH-4784717", "source_name": "Investing.com", "published_at": "2026-07-10T09:10:45", "published_display": "10 Jul 2026 09:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna Inc stock hits all-time high at 38.01 USD By Investing.com", "summary": "Septerna Inc's stock has reached an all-time high of $38.01, bringing its market capitalization to $1.71 billion. The company has seen a 224.66% increase in its stock price over the past year, reflecting strong investor confidence and strategic advancements. Analysts have varied ", "url": "https://in.investing.com/news/stock-market-news/septerna-inc-stock-hits-alltime-high-at-3801-usd-93CH-5490140", "source_name": "Investing.com India", "published_at": "2026-07-09T21:09:17", "published_display": "09 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$SEPN stock is up 10% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOaFRISk56a2lIZUtJVFZNS2puWjhhcFV4dU5pM2dvaGE2WEcxY0dFcHozdGQyOU5SQm5iVGU5cFRHRXVSeUVCRVlXREtfYVZwbUowRWZwN1BZMTdnbjNOZFJ1VVRMa0dWTkk3a05aaXZLbWxlQkEtRGctTm4xcXAwYTBiUEFreEUzUUJkYXROU3VnY1V1cDM2emk4MVFZS3VX?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-07T14:51:00+00:00", "published_display": "07 Jul 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Septerna, Inc. (SEPN)", "summary": "This article analyzes the hypothetical return on a $1,000 investment in Septerna, Inc. (SEPN), a clinical-stage biotechnology company specializing in GPCR-targeted therapies. An investment made one year ago would have yielded a 213.4% return, turning $1,000 into $3,134. The compa", "url": "https://www.stocktitan.net/tools/stock-return-calculator/SEPN", "source_name": "Stock Titan", "published_at": "2026-07-04T07:11:05", "published_display": "04 Jul 2026 07:11", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) SVP Long exercises options and sells 3,333 shares in Rule 10b5-1 trades", "summary": "Daniel D. Long, Senior Vice President of Drug Discovery at Septerna, Inc. (SEPN), exercised stock options to acquire 3,333 shares at $2.76 each and simultaneously sold these 3,333 shares in open-market transactions on July 1, 2026. The sales were conducted under a pre-arranged Ru", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-5138f5c509e8.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:39:28", "published_display": "02 Jul 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Strategy (MSTR)", "summary": "Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Septerna, Inc. (SEPN) with a $45.00 price target, reflecting a current consensus Strong Buy with a 38.9% upside. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating on Strategy (MSTR) with a $130.00 price ta", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3095991/analysts-offer-insights-on-technology-companies-septerna-inc-sepn-and-strategy-mstr/", "source_name": "The Globe and Mail", "published_at": "2026-07-02T11:14:42", "published_display": "02 Jul 2026 11:14", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPSmo4YkZqRzB2WkVGaVVqYmoxTXJRX3d0eXB2eU9heGM5cmVlNElpNG9zX0RaeUdOZzRQVEJ2MGFSUTZncmp4clZaaFdrZUc1M2NlcnN1Nmp5ODk1eFl6eXBQNWtxcENYbi03b2dSVGtzaWd4Um5ZaGVtRjhCalNQU2NaRDQwaFdtbGNiU1FjMlg5THVmX0tR?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Securities Adjusts Septerna Price Target to $43 From $35, Maintains Buy Rating", "summary": "Truist Securities has increased its price target for Septerna, Inc. (NasdaqGM:SEPN) to $43 from $35, while reiterating a \"Buy\" rating on the stock. This adjustment reflects an updated positive outlook from the firm regarding the biotechnology company. Septerna is a clinical-stage", "url": "https://www.marketscreener.com/news/truist-securities-adjusts-septerna-price-target-to-43-from-35-maintains-buy-rating-ce7f5fd2d98ff026", "source_name": "www.marketscreener.com", "published_at": "2026-07-01T12:42:24", "published_display": "01 Jul 2026 12:42", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) Is Down 7.1% After Broad Russell Index Additions Has The Bull Case Changed?", "summary": "Septerna, Inc. (NasdaqGM: SEPN) was recently added to several Russell growth and small-cap indexes in late June 2026, which could increase its visibility among institutional investors. Despite a recent 7-day share price decline, this index inclusion primarily impacts trading liqu", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-is-down-71-after-broad-russell-index-additions", "source_name": "Simply Wall Street", "published_at": "2026-07-01T12:42:24", "published_display": "01 Jul 2026 12:42", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna stock maintained at Buy by H.C. Wainwright after rival setback", "summary": "H.C. Wainwright has reiterated a Buy rating and a $40 price target for Septerna Inc (NASDAQ:SEPN) despite a competitor's negative Phase 2b data in chronic spontaneous urticaria. The firm maintains that Septerna's drug SEP-631, which targets the same condition, still has potential", "url": "https://ca.investing.com/news/stock-market-news/septerna-stock-maintained-at-buy-by-hc-wainwright-after-rival-setback-93CH-4715918", "source_name": "Investing.com Canada", "published_at": "2026-07-01T11:42:24", "published_display": "01 Jul 2026 11:42", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim cuts Septerna stock price target to $45 on CSU study risk", "summary": "Guggenheim lowered its price target for Septerna Inc. (NASDAQ:SEPN) to $45 from $52, while maintaining a Buy rating. This adjustment follows a competitor's failed Phase 2b study for chronic spontaneous urticaria (CSU), increasing the perceived risk for Septerna's similar drug can", "url": "https://www.investing.com/news/analyst-ratings/guggenheim-cuts-septerna-stock-price-target-to-45-on-csu-study-risk-93CH-4770149", "source_name": "Investing.com", "published_at": "2026-07-01T07:26:06", "published_display": "01 Jul 2026 07:26", "sentiment": "negative", "sentiment_pct": 40, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director Abraham Bassan receives grant of 15,000 stock options", "summary": "Septerna, Inc. director Abraham Bassan was granted 15,000 stock options with an exercise price of $37.34 per share, expiring on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the date of Septerna's next annual meeting of stockholders, provided ", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-c38ef471a367.html", "source_name": "Stock Titan", "published_at": "2026-07-01T06:09:26", "published_display": "01 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna chief people officer Samira Shaikhly sells $76,622 in stock", "summary": "Samira Shaikhly, Septerna's Chief People Officer, sold 2,178 shares of the company's common stock for $76,622 after exercising stock options. The sale was conducted under a Rule 10b5-1 trading plan. This transaction follows a significant 216% surge in Septerna's share price over ", "url": "https://m.uk.investing.com/news/stock-market-news/septerna-chief-people-officer-samira-shaikhly-sells-76622-in-stock-93CH-4751763?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-01T05:39:52", "published_display": "01 Jul 2026 05:39", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director Jeffrey Tong granted options on 15,000 shares", "summary": "Septerna, Inc. director Jeffrey K. Tong was granted stock options for 15,000 shares of common stock. The options have an exercise price of $37.34 per share and expire on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the date of Septerna\u2019s next", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-fef761c8d72a.html", "source_name": "Stock Titan", "published_at": "2026-07-01T05:39:52", "published_display": "01 Jul 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director Bernard Coulie receives 15,000 stock options", "summary": "Septerna, Inc. (SEPN) director Bernard Coulie was granted 15,000 stock options with an exercise price of $37.34 per share, expiring on June 25, 2036. The options will vest in full by the earlier of June 26, 2027, or the company's next annual stockholders' meeting, provided he con", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-e355f5e8dfdf.html", "source_name": "Stock Titan", "published_at": "2026-07-01T00:42:24", "published_display": "01 Jul 2026 00:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (NASDAQ: SEPN) director-linked funds get 15,000-share option", "summary": "Septerna, Inc. (NASDAQ: SEPN) has granted a stock option for 15,000 shares of common stock at an exercise price of $37.34, expiring on June 25, 2036. This option, which vests upon the earlier of June 26, 2027, or the next annual stockholder meeting, is held by Dr. Simson for the ", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-4aef99e2cf47.html", "source_name": "Stock Titan", "published_at": "2026-07-01T00:39:52", "published_display": "01 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director Shalini Sharp receives stock options on 15,000 shares", "summary": "Septerna, Inc. director Shalini Sharp was granted stock options for 15,000 shares of common stock. The options have an exercise price of $37.34 per share and will expire on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the company's next annua", "url": "https://www.stocktitan.net/sec-filings/SEPN/form-4-septerna-inc-insider-trading-activity-136ae8e4ccbb.html", "source_name": "Stock Titan", "published_at": "2026-06-30T22:42:24", "published_display": "30 Jun 2026 22:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $60", "summary": "Cantor Fitzgerald has reiterated its Buy rating for Septerna (SEPN.US) and increased the price target to $60. This adjustment reflects the firm's continued positive outlook on the company's stock performance.", "url": "https://www.moomoo.com/news/post/72262745/cantor-fitzgerald-maintains-septerna-sepnus-with-buy-rating-raises-target", "source_name": "Moomoo", "published_at": "2026-06-30T16:39:52", "published_display": "30 Jun 2026 16:39", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (SEPN) director receives stock option grant for 11,260 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUG5vOHJILWlLR19tcmlONkUwakNUbHRCT0FhZ3FGTm1NNkF6a0NZY3dVYTJyNENiMXFwX0hTWVRyS0VGazRFM3pEVzc1OW83NlkwXzF6ZHpyMGgzSjBmTXBvem9xTEoyYndnNTNwbnlIWjNFNFNVUTBhTmZuOXU2Q3MwUjJOVGRfTUlZUE00LXliV1cwSE0zREZ1Y3F3Zlc5Q2VBSjFhblBrQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna (NASDAQ: SEPN) 2026 meeting elects directors and backs EY as auditor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPdUhfdWR5VTcyWGt6R080S3FKUUJYRlg3MEdkYVNMWGpqS0FFejZrcXVyV1FoQzNINXdITzc3R1BFU095Njd0aWY0VUtzV2pWR0dnZWlBZjlpRUpQelZHNmYza3ozblhndGpJLTY2QmZzN09sdlJ5MC00Wm5DcVRKNXo3UEtKNmJBMjNBVEpsRkRlWjJONXBqeWJ3VEJQX2dab2xN?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?", "summary": "An insider at Septerna, Daniel D. Long, SVP of Drug Discovery, sold 15,000 shares of common stock after exercising options, reducing his direct holdings by 13.46%. Despite this sale, the article suggests it's likely a form of income supplementation rather than a lack of confidenc", "url": "https://finance.yahoo.com/markets/stocks/articles/septerna-stock-sell-insider-let-032501051.html", "source_name": "Market source", "published_at": "2026-06-30T03:10:47", "published_display": "30 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Septerna, Inc. Stocks", "summary": "This article lists various ETFs that hold Septerna, Inc. (SEPN) stocks, providing detailed information such as market value, weight, issuer, management style, focus, and expense ratio for each fund. The data highlights ETFs from major issuers like BlackRock, State Street, and Inv", "url": "https://www.tradingview.com/symbols/NASDAQ-SEPN/etfs/", "source_name": "TradingView", "published_at": "2026-06-29T16:10:47", "published_display": "29 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna, Inc.(NasdaqGM:SEPN) added to Russell 2000 Growth Benchmark", "summary": "Septerna, Inc. (NasdaqGM: SEPN) has been included in the Russell 2000 Growth Benchmark, a significant development for the clinical-stage biotechnology company. This inclusion indicates increased visibility and potential liquidity for Septerna's stock. The company focuses on devel", "url": "https://www.marketscreener.com/news/septerna-inc-nasdaqgm-sepn-added-to-russell-2000-growth-benchmark-ce7f5fded18dfe21", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T11:11:27", "published_display": "29 Jun 2026 11:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SEPN (NASDAQ) insider sale: JAE KIM sells 94,339 shares under Rule 144", "summary": "JAE KIM, an insider at Septerna, Inc. (NASDAQ: SEPN), sold 94,339 shares of common stock on June 22, 2026, for proceeds of $3,326,119.56, as reported in a Rule 144 filing on June 26, 2026. This notice details proposed transactions of restricted shares and also lists prior Employe", "url": "https://www.stocktitan.net/sec-filings/SEPN/144-septerna-inc-sec-filing-47f6ebded44f.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:40:02", "published_display": "26 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Party Time: Brokers Just Made Major Increases To Their Septerna, Inc. (NASDAQ:SEPN) Earnings Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQNUZyR3E3WkNKX0l5MWpraTBOWWtDeEl6ZXRmZzF1LXVFVFVQVnJ1VXJDaFYyRnAtamlwNG5HbXQ3a0FBTExKby0wUHBMd1FVRVhjOV94aWJYY3pRc1p3QjR0bWpBZHdmT0dPTUNtLW5DN2JuaG4wRVNrZ2NfVFl5cS11TWwzMHlveHNrUzRxMmQ5MWhSdHk3bQ?oc=5", "source_name": "Market source", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Septerna, Inc. (NASDAQ:SEPN) Just Reported And Analysts Are Boosting Their Estimates", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/earnings-septerna-inc-nasdaq-sepn-140848094.html", "source_name": "Simply Wall St.", "published_at": "2026-05-15T14:08:48+00:00", "published_display": "15 May 2026 14:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPRHVXU0Z5SEpiVXp2TGNMS0drQ2J1M0R6N0wxS1oxcGh1R1ZrYWFySVNuQ0ZQNzlDS09tVkJ2SVJnYjdmdFBXZ3VrdUR2OXViWUZPSVV2UHByYnVyanFDcGpwSkhiV1FDYkhLYVNaMDl3UDE2VFFPd01FTGx1YVZ6dkkxX21uNVhzNm5nd05YRE8yTWQ2bk5RRA?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 87, "total_relevant": 51, "sentiment_summary": {"positive": 18, "negative": 5, "neutral": 28, "score": 56, "total": 51, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 15.2, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 9.29, "count": 18}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 18, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 35.93, "latest_week": "2026-07-10", "one_week_move": 5.7, "four_week_move": -0.1, "twelve_week_move": 37.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.30528, "market_dynamics_buy_signal": false, "relative_strength": 30.47164, "fair_value_gap": 82.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 52.3852, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.7% over one week, -0.1% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 11}, {"label": "Stock Titan", "count": 11}, {"label": "Investing.com", "count": 4}, {"label": "Quiver Quantitative", "count": 2}, {"label": "www.marketscreener.com", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "TIKR.com", "count": 2}, {"label": "Barron's", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 44}, {"label": "Industry context", "count": 7}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 18}, {"label": "Analyst action", "count": 5}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "44", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+5.7% over one week, -0.1% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Septerna president & COO Elizabeth Bhatt sells $135,974 in stock"}], "updated_at": "2026-07-18T08:56:32.368740+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}